The diabetes drug Actos is sold by Takeda Pharmaceuticals North America, which is the American subsidiary of Japanese drug manufacturer Takeda Pharmaceutical Company Limited.
Takeda is one of the oldest pharmaceutical companies in the world, founded on June 12, 1781. It is also the largest drug company in Japan and Asia, and ranks among the largest 15 drug companies in the world.
Takeda Pharmaceuticals was incorporated in 1925, but did not enter the United States drug market until 1977, when the company partnered with Abbott Laboratories to form TAP Pharmaceuticals. Together, the companies marketed the blockbuster drugs Lupron and Prevacid.
Today, Actos is one of Takeda’s most popular drugs. It was originally launched in 1999 to compete with rival Avandia. However, after Avandia was heavily restricted due to heart complications, Actos became the most widely-prescribed diabetes drug in the world. From 2008 to 2010, Takeda earned over $10 billion from sales of Actos.
Unfortunately, experts have now linked long-term use of Actos to an increased risk of bladder cancer. Despite widespread warnings, Takeda continues to sell the drug to consumers. They now face substantial legal liability from those affected.
If you or a loved one have been diagnosed with bladder cancer after taking Actos, it is important to speak with a lawyer about your legal rights. You may be entitled to substantial compensation, however, time to file a claim is limited.
In 2010 alone, more than 2 million people in the United States were prescribed Actos. Although more than 1,000 patients have already filed a claim for bladder cancer, experts expect as many as 10,000 patients may have been affected.
Experts first warned of the dangers of Takeda’s drug in March of 2011, when Germany and France banned Actos after a study showed extended use could increase bladder cancer risks by as much as 40%.
The FDA issued its own Actos warning in June of 2011, however, they have not recalled the drug from the market.
In April of 2012, Health Canada added their own warning about Actos. The next month, the British Medical Journal published a study from McGill University in Montreal showing that long-term use of Actos may actually increase the risks of bladder cancer by as much as 83%.
If you or a loved one have been affected by bladder cancer after taking Actos, it is important to speak with a lawyer about the current litigation, whether your case qualifies, and how long you have to take action.
The Drug Risk Resource Center cautions victims that they should seek a lawyer with the resources and experience necessary for complex defective drug litigation. DrugRisk only recommends lawyers and law firms who have already handled Actos lawsuits.
Contact us today for more information on the research, side effects and litigation news related to Actos, or to speak with a lawyer. We are available 24 hours a day to provide help.